Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial.

@article{Meredith2009ClinicalAA,
  title={Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial.},
  author={Ian T. Meredith and Stephen G. Worthley and Robert J. Whitbourn and Darren Walters and Dougal Mcclean and Mark L Horrigan and Jeffrey J. Popma and Donald E. Cutlip and A Depaoli and Manuela Negoita and Peter J. Fitzgerald},
  journal={JACC. Cardiovascular interventions},
  year={2009},
  volume={2 10},
  pages={977-85}
}
OBJECTIVES The RESOLUTE trial examined the safety and efficacy of a next-generation zotarolimus-eluting coronary stent, Resolute (Medtronic CardioVascular Inc., Santa Rosa, California). BACKGROUND Revascularization benefits associated with current drug-eluting stents are often diminished in the presence of complex coronary lesions and in certain patient… CONTINUE READING